Long-Term Morbidity Seen for Benign Paroxysmal Positional Vertigo

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 21, 2026.

via HealthDay

THURSDAY, May 21, 2026 -- Despite successful initial treatment, significant long-term morbidity is seen for patients with benign paroxysmal positional vertigo (BPPV), according to a study published online April 21 in Otolaryngology-Head and Neck Surgery.

Eduardo Martin-Sanz, Ph.D., from Getafe University Hospital in Madrid, Spain, and colleagues examined long-term outcomes in patients successfully treated for BPPV over a seven-year follow-up period. A total of 361 patients treated between May 2011 and March 2017 were included in the study.

Overall, the mean patient age was 63.3 ± 15.6 years, with more female than male patients (2.2:1). The most affected area was the posterior canal (86.7 percent). The researchers found that 47.1 percent of patients had recurrence over seven years. Residual dizziness increased from 29.6 percent at one month to 37.6 percent at long-term follow-up. Overall, 18.9 percent of patients reported falls. Recurrence was predicted by requiring multiple repositioning maneuvers and vestibular rehabilitation (odds ratios, 3.89 and 2.41, respectively). There was an association for residual dizziness with increased fall risk (odds ratio, 5.7) and elevated Dizziness Handicap Inventory scores.

"These ongoing symptoms carry meaningful functional consequences, including increased fall risk and higher perceived disability," the authors write. "The findings highlight the importance of structured follow‐up and early identification of patients at greater risk to guide preventive and personalized management strategies."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-22 02:48

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords